ReviewClinical oral investigations2025
AIM2 and IFI16 as nucleic acid sensors in Periodontitis-Driven systemic inflammation: emerging evidence and therapeutic implications.
Review in Clinical oral investigations, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
objectivesThis review aims to investigate the roles of Absent in Melanoma 2 (AIM2) and Interferon Gamma Inducible Protein 16 (IFI16), as innate immune sensors for cytosolic double-stranded DNA (dsDNA), in the pathogenesis of periodontal disease. Furthermore, this article discusses the significance of these proteins in the interplay between periodontal disease and systemic health conditions. DATA SOURCES: This review comprehensively analyzes the involvement of AIM2 and IFI16 in the pathogenesis of periodontal disease, particularly their roles in inflammasome formation and the promotion of IL-1 secretion, through a review of relevant literature. A literature search was conducted using PubMed, Scopus, and Google Scholar databases. Search terms included "AIM2," "IFI16," "periodontitis," "inflammasome," and "systemic inflammation." Only English-language original research articles and reviews were included. STUDY SELECTION: Studies related to AIM2 and IFI16, especially those examining their roles in periodontitis and systemic diseases, were selected for analysis.
conclusionsEvidence indicates that several inflammasomes, including AIM2 and IFI16, are involved in the pathogenesis of periodontal disease. Polymorphisms in AIM2 and IFI16 genes are linked to an increased severity of periodontal disease. These inflammasomes respond to pathogen or tissue "danger" signals by creating multiprotein complexes that cleave the proinflammatory mediator IL-1 into its active form. The study highlights the pivotal role of AIM2 and IFI16 in periodontitis and systemic diseases, particularly in how they shift from homeostasis to disease states in both periodontitis and systemic conditions. CLINICAL SIGNIFICANCE: Given that periodontitis is an inflammatory dysbiosis illness affecting overall health, research into inflammasomes like AIM2 and IFI16 is not only significant for understanding the pathogenesis of periodontal disease but also holds clinical relevance in preventing and treating related systemic conditions.
Indexed as
Identifiers
41028172What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.